Clinical Trial: A Study on Recombinant Botulinum Toxin Type A (YY001) for Injection in Multiple Treatments of Adult Upper Limb Spasticity

U.S., March 19 -- ClinicalTrials.gov registry received information related to the study (NCT07478822) titled 'A Study on Recombinant Botulinum Toxin Type A (YY001) for Injection in Multiple Treatments of Adult Upper Limb Spasticity' on March 11.

Brief Summary: This is an open-label, multicenter, phase III clinical study to evaluate the long-term safety and efficacy of multiple treatments with recombinant botulinum toxin type A (YY001) for injection in adult upper limb spasticity

Study Start Date: March 20

Study Type: INTERVENTIONAL

Condition: Upper Limb Spasticity

Intervention: BIOLOGICAL: Recombinant botulinum toxin type A for injection (YY001)

Prepared by reconstitution of powder with 0.9% Sodium Chloride (NaCl), intramuscular inj...